Vicarious Surgical (RBOTW) Debt to Equity (2021 - 2022)
Vicarious Surgical (RBOTW) reported Debt to Equity of $0.01 for Q3 2022, down 68.34% year-over-year from $0.02 in Q3 2021, and up 2.06% quarter-over-quarter from $0.01 in Q2 2022.
Vicarious Surgical (RBOTW) Debt to Equity (2021 - 2022) Analysis & Trends
Vicarious Surgical (RBOTW) has 2 years of Debt to Equity data on file, last reported at $0.01 in Q3 2022.
- Debt to Equity for Q3 2022 came in at $0.01, down 68.34% year-over-year; the trailing twelve-month figure through Sep 2022 was $0.01 (down 68.34% YoY), and the FY2021 annual result was $0.02, changed N/A from the prior year.
- Debt to Equity climbed to $0.01 in Q3 2022 per RBOTW's latest filing, from $0.01 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.02 in Q3 2021 and troughed at $0.01 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.71 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 0.27 |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.02 |